Abstract
OBJECTIVE: In the current study the role of developing ovarian follicles in the control of the endotoxin-induced pregnancy-specific inflammatory reaction was evaluated.
STUDY DESIGN: Follicular development was induced in pregnant rats (n = 20) by means of daily intraperitoneal injections of follicle-stimulating hormone from day 11 of pregnancy until the end of the experiment. Control pregnant rats (n = 20) received daily sodium chloride injections. All pregnant rats were infused for 1 hour with either 2 mL endotoxin solution (1.0 mu g/kg body weight) or 2 mt sodium chloride solution on day 14 and killed 4 hours or 3 days later. At death, the left kidneys were snap-frozen and immunohistologically stained for the presence of polymorphonuclear leukocytes and monocytes.
RESULTS: The results show that in control pregnant rats endotoxin significantly increased glomerular poly morphonuclear leukocyte and monocyte numbers at both 4 hours and 3 days after endotoxin infusion. induction of follicular development did not affect glomerular polymorphonuclear leukocyte number after endotoxin infusion but significantly decreased the number of monocytes in the glomeruli at both 4 hours and 3 days after endotoxin infusion.
CONCLUSION: We conclude that follicles stimulated with follicle-stimulating hormone produce a follicular factor or factors that are able to prevent the endotoxin-induced influx of monocytes into the glomeruli of pregnant rats. It is suggested that these factors play a role in the control of inflammatory processes associated with reproduction, including the disease of pregnancy, preeclampsia.
Original language | English |
---|---|
Pages (from-to) | 89-93 |
Number of pages | 5 |
Journal | American Journal of Obstetrics and Gynecology |
Volume | 183 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jul-2000 |
Keywords
- pregnancy
- endotoxin
- ovarian follicles
- polymorphonuclear leukocytes
- monocytes
- ACTIVIN-A
- PREECLAMPSIA
- CELLS
- INHIBIN
- IMPLANTATION
- SENSITIVITY
- LEUKOCYTES
- INFUSION
- IMMUNE